cancer treatment

Showing 13 posts of 13 posts found.

MHRA sign

Astellas prostate cancer drug gets third approval from MHRA

May 12, 2021
Research and Development Astellas, MHRA, cancer research, cancer treatment, pharma, pharma news, prostate cancer

The MHRA has approved Astellas Pharma’s XTANDI (enzalutamide) drug for the treatment of a third form of prostate cancer, making …

NICE rejects Merck Serono’s Bavencio for urothelial cancer

May 10, 2021
Sales and Marketing MSD, Merck, NHS, NICE, cancer treatment, pharma, pharma news

The use of avelumab for maintenance treatment of locally advanced or metastatic urothelial cancer after platinum-based chemotherapy is not recommended by …

Merck kidney and uterus cancer treatments granted priority review by FDA

May 7, 2021
Medical Communications FDA, MSD, Merck, cancer treatment, kidney cancer treatment, pharma, pharma news, uterus cancer treatment

The FDA has granted priority review for Merck (MSD) and Eisai’s application for two new approvals for the combination of …

Researchers find possible new treatment for several cancers

April 23, 2021
Medical Communications Cancer, The Institute of Cancer Research, cancer treatment, kidney cancer treatment, pharma, pharma news

Researchers at The Institute of Cancer Research (ICR) in London have discovered a new use for an ovarian and breast …

Amgen flag

Amgen stomach cancer drug awarded Breakthrough Therapy Designation

April 21, 2021
Research and Development Amgen, Cancer, cancer treatment, pharma, pharma news

Amgen’s investigational therapy, bemarituzumab, for certain types of stomach and esophagus cancer, has been granted Breakthrough Therapy Designation by the …

Exscientia enter first-ever AI cancer drug into Phase I trials

April 9, 2021
Medical Communications AI, Evotec, Exscientia, cancer treatment, oncology, pharma, pharma news

Exscientia and Evotec have announced that they are entering an AI-designed immuno-oncology drug into Phase I trials for the first …

Takeda building

Takeda acquire Maverick in $525m deal to expand cancer therapy portfolio

March 10, 2021
Research and Development Maverick, Takeda, cancer treatment

Takeda has acquired Maverick Therapeutics in a deal worth up to $525 million, in order to expand its portfolio of …

Merck building

Merck and Debiopharm agree €898m deal to develop head and neck cancer treatments

March 1, 2021
Sales and Marketing Debiopharm, Merck, cancer treatment, head and neck cancer, xevinapant

German science and technology company Merck have agreed a worldwide in-licensing agreement with Debiopharm for the development and commercialisation of …

ONK and Anthony Nolan combine forces to work on blood cancer therapies

February 22, 2021
Sales and Marketing Anthony Nolan, Cancer, ONK, blood cancer, cancer treatment

ONK Therapeutics and blood cancer charity Anthony Nolan will work together on therapies for patients with haematological malignancies (blood cancers) …

New Cell Guidance technology has potential to help treat cancer

February 19, 2021
Medical Communications Cancer, cancer treatment, cell guidance systems, macrophages, pharma news

Cell Guidance Systems’ new POlyhedrin Delivery System (PODS) technology has been shown to have therapeutic potential in the treatment of …


AI may help predict patient response to non-small cell lung cancer therapies

March 23, 2020
Medical Communications, Sales and Marketing Cancer, Lesions, cancer treatment, tumour treatment

Researchers have used artificial intelligence to train algorithms to predict tumour sensitivity to systemic cancer therapies. Radiologists previously determined if …


Landmark study set to transform cancer treatment

February 6, 2020
Business Services Cancer, cancer breast, cancer mutations, cancer research, cancer treatment

Over a thousand scientists have built the most detailed picture of cancer ever in a landmark study. Their research was …

China approves Roche cancer drug Kadcyla

January 22, 2020
Business Services China, Roche, breast cancer, cancer treatment, oncology

China has approved the import of Roche’s drug for breast cancer, just after it recently won expanded approval in the …

Latest content